Impact of anxiety therapy on patients' quality of life.
The treatment of anxiety is one of the leading problems in medicine today. Although traditional anxiolytic drugs have been effective in reducing the symptoms of anxiety, their efficacy has often been achieved at the expense of the patient's quality of life. The sedative side effects and impaired psychomotor functioning associated with the use of benzodiazepine anxiolytics not only impede the success of therapy, but jeopardize the patient's safety. This article addresses these salient issues and provides evidence suggesting that the antianxiety drug buspirone better achieves the goal of optimal anxiolytic therapy with minimal unwanted effects.
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001334:Automobile Driving; D002065:Buspirone; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D011597:Psychomotor Performance / Q000187:drug effects; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use; D011788:Quality of Life; D012894:Sleep Stages
D014151:Anti-Anxiety Agents; D011743:Pyrimidines; D000431:Ethanol; D003975:Diazepam; D002065:Buspirone